Free Trial

Dimensional Fund Advisors LP Grows Position in Select Medical Holdings Co. (NYSE:SEM)

Select Medical logo with Medical background

Dimensional Fund Advisors LP raised its position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,431,681 shares of the health services provider's stock after acquiring an additional 48,300 shares during the period. Dimensional Fund Advisors LP owned approximately 3.46% of Select Medical worth $104,147,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp bought a new position in Select Medical during the third quarter valued at $29,000. GAMMA Investing LLC bought a new position in shares of Select Medical in the fourth quarter worth about $33,000. Covestor Ltd grew its holdings in shares of Select Medical by 74.9% in the third quarter. Covestor Ltd now owns 4,292 shares of the health services provider's stock worth $108,000 after purchasing an additional 1,838 shares during the last quarter. CI Investments Inc. bought a new position in shares of Select Medical in the third quarter worth about $147,000. Finally, Sigma Planning Corp bought a new position in shares of Select Medical in the third quarter worth about $209,000. Institutional investors own 89.48% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently commented on SEM. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, March 22nd. Benchmark restated a "buy" rating and issued a $39.00 price target on shares of Select Medical in a report on Friday, May 3rd. Finally, Royal Bank of Canada upped their price target on shares of Select Medical from $36.00 to $40.00 and gave the stock an "outperform" rating in a report on Monday, May 6th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $34.25.


Read Our Latest Stock Analysis on Select Medical

Insider Buying and Selling at Select Medical

In other Select Medical news, Chairman Robert A. Ortenzio sold 50,000 shares of the stock in a transaction dated Monday, April 8th. The shares were sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the completion of the sale, the chairman now directly owns 6,689,668 shares of the company's stock, valued at $200,021,073.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 17.50% of the company's stock.

Select Medical Stock Down 0.6 %

NYSE:SEM traded down $0.21 during mid-day trading on Wednesday, reaching $34.03. The company's stock had a trading volume of 663,935 shares, compared to its average volume of 581,589. Select Medical Holdings Co. has a 1 year low of $21.28 and a 1 year high of $35.08. The stock has a fifty day moving average of $29.80 and a 200-day moving average of $26.85. The firm has a market capitalization of $4.42 billion, a PE ratio of 16.27, a price-to-earnings-growth ratio of 1.60 and a beta of 1.38. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Friday, February 23rd. The health services provider reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. The company had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.64 billion. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. The firm's revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 earnings per share. Equities research analysts forecast that Select Medical Holdings Co. will post 2.1 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 30th. Shareholders of record on Thursday, May 16th will be given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.47%. The ex-dividend date of this dividend is Wednesday, May 15th. Select Medical's payout ratio is 23.81%.

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should you invest $1,000 in Select Medical right now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines